Less than two years after scoring its first FDA clearance, Akili Interactive is betting big on its digital therapeutic technology. The Massachusetts-based company has signed a reverse-merger deal with ...

After announcing it would start selling its assets earlier this year and lay off nearly half the company, the medical app developer Akili Interactive has found a willing buyer. Virtual Therapeutics, ...

Akili Interactive (“Akili” or the “Company”), a leading digital medicine company developing cognitive treatments through game-changing technologies, has entered into a definitive agreement to become ...

Akili, maker of a video game-like digital therapeutic for children with ADHD, hit the public markets Monday after wrapping up a merger with special-purpose acquisition company Social Capital Suvretta ...

Akili, Inc. (Nasdaq: AKLI), a leading digital medicine company, will participate in the Cowen 43 rd Annual Health Care Conference in Boston next month. On March 8, Akili sessions are scheduled for the ...

Akili’s newly launched treatment for ADHD is a prescription—but not a drug. It's a video game. And the company is taking a fittingly digital approach to launching the first-of-its-kind FDA-approved ...

Following its recent $30 million fundraise to advance its video game platform for neurological conditions such as attention deficit hyperactivity disorder and Alzheimer’s disease, Akili Interactive ...

BOSTON--(BUSINESS WIRE)--Akili Interactive (“Akili”), a leading digital medicine company pioneering the development of cognitive treatments through game-changing technologies, today announced the ...